Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
FDA flags 3.1 million store-brand eye drops recalled over sterility concerns
More than 3.1 million bottles of store-brand eye drops sold at CVS, Walgreens $WBA 0.00%, Kroger, and other major retailers have been voluntarily recalled after the Food and Drug Administration cited a “lack of assurance of sterility” from the manufacturer, KC Pharmaceuticals of Pomona, California.
The recall affects 3,111,072 bottles from eight product lines, all made by KC Pharmaceuticals and sold under different store brands. Products include Dry Eye Relief Eye Drops, Sterile Eye Drops, Advanced Relief Eye Drops, and Artificial Tears Sterile Lubricant Eye Drops. The recalled bottles have expiration dates between April 30 and July 31, 2026.
Related Content
Wawa recalls 4 bottled drinks in 5 states over undeclared milk allergen
Novo Nordisk says its Wegovy pill beats Eli Lilly’s rival on weight loss
The voluntary recall began on March 3. By March 31, the FDA had labeled it as a Class II recall. This category is for products where health risks are usually temporary and reversible, or where serious harm is unlikely. Regulators said that serious harm from these products is unlikely.
No contamination has been found, and there have been no reports of injuries or infections linked to these products. The FDA notice did not say what caused the recall, and KC Pharmaceuticals has not yet responded to requests for comment from news outlets.
Under typical Class II recall guidance, the FDA does not require people to immediately stop using the affected product, provided the manufacturer has not issued separate instructions to do so. Refunds are available for anyone who bought the recalled products and wishes to bring them back to the retailer. A CVS spokesperson, speaking to ABC News, noted that the chain’s four implicated products had already been pulled from its shelves roughly a year earlier, and confirmed the retailer’s support for the recall process.
The recalled products were sold under multiple store brand names, including CVS, Walgreens, Kroger, H-E-B, Rite Aid, Discount Drug Mart, Gericare, and Best Choice. A full list of affected products, including lot numbers and UPC codes, is available on the FDA’s website.
Non-sterile eye drops carry the risk of bacterial or fungal contamination. Dr. Nicole Bajic, an ophthalmologist at the Cleveland Clinic, warned that sterility in eye drops is non-negotiable. “Whenever we talk about using eye drops for the ocular system, it’s really important that there’s no bacterial contamination because that can cause significant and sight-threatening infections,” she told Yahoo News. Bajic advised anyone whose symptoms — including pain, visual disturbances, or sensitivity to light — are not resolving on their own to consult a doctor promptly.
📬 Sign up for the Daily Brief
Our free, fast and fun briefing on the global economy, delivered every weekday morning.
Sign me up